Healthcare Professionals Portal »
Your browser can’t play HTML5 video. Download it instead.
Choosing to take an omega-3 will provide your body the necessary nutrients for optimal tear composition and overall eye health. Choosing the right omega-3 is just as important. Omega-3’s rich in EPA and DHA in their natural triglyceride form will enhance your therapeutic outcome. PRN Physician Recommended Nutriceuticals® provides the purest, most therapeutically potent omega-3 based nutriceuticals possible. All of PRN’s omega-3 based products, when taken as recommended, deliver a therapeutic amount of omega-3 EPA and DHA as recommended by the American Heart Association.
Click here to learn more about the use of omega-3s for macular health and relief of dry eye symptoms
Omega-3 essential fatty acids are an important nutrient for growth and development throughout all stages of human life.
Over 20,000 clinical studies have shown the benefits of fish oil (i.e., marine-based omega-3 fatty acids) across a multitude of health conditions. Most North Americans, though, still suffer from harmful omega-3 deficiency resulting in between 72,000 and 96,000 preventable deaths each year.1
Click here to learn more about the benefits of omega-3s for your health and the differences between the currently available brands.
1 US National Health center for Health Statistics, 2005 data
Though many nutritional supplements including omega-3s are available, PRN Physician Recommended Nutriceuticals provides products with unmatched purity and potency, and the endorsement of the world’s leading doctors and medical thought leaders. In addition, PRN is dedicated to providing products that meet the following high standards:
Click here to learn more about the PRN difference
Maybe you’re not getting relief from your store-bought brand, or your doctor says you need to start on the only product clinically proven to maximize your body’s absorption of omega-3s.
Whether you still have questions or want to follow through with your doctor’s recommendation...
Dr. Gregory Smith, world-renowned ophthalmologist and Attending Surgeon at the famed Wills Eye Hospital in Philadelphia, presented new study data at the Cornea Society/EBAA Fall Educational Symposium that could significantly enhance the way posterior blepharitis/Meibomian Gland Dysfunction is treated. Smith’s abstract, entitled “Penetration of rTG omega-3 into the meibomian glands after oral administration” provided the first evidence that omega-3 can change the composition of the oil in the meibum, which contributes to the lipid layer of the tear.